Second transplantation with CD34+ bone marrow cells selected from a two-loci HLA-mismatched sibling for a patient with chronic myeloid leukaemia

Br J Haematol. 1996 Jul;94(1):123-5. doi: 10.1046/j.1365-2141.1996.d01-1763.x.

Abstract

A 43-year-old man with chronic myeloid leukaemia underwent a second transplant with CD34+ bone marrow cells selected from his two-loci HLA-mismatched sibling after rejection of the first graft from an HLA-matched unrelated donor. By immunomagnetic positive selection, CD34+ marrow cells at 0.95 x 10(6)/kg with 97% purity and CD3+ T lymphocytes at 1.3 x 10(4)/kg were collected and transplanted. Engraftment was confirmed to be of CD34+ cell-donor origin. The patient developed only grade I acute graft-versus-host disease (GVHD) and no chronic GVHD to date. These observations suggest that allogeneic CD34+ bone marrow cells are capable of reconstituting haemopoiesis and that CD34+ selection could be applicable to T-cell depletion.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antigens, CD34*
  • Antilymphocyte Serum / therapeutic use
  • Bone Marrow Transplantation / methods*
  • Graft Rejection
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / prevention & control
  • Histocompatibility Testing
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Lymphopenia / etiology
  • Male
  • T-Lymphocytes

Substances

  • Antigens, CD34
  • Antilymphocyte Serum